Product Information
TADLIQ 20 MG/5 ML SUSPENSION is a brand product labeled by CMP Pharma, Inc., priced at $13.5931 per ML under NDC 46287004515. Its NADAC has been published 85 times since Jun 19, 2024.
FDA first approved this application on Jun 17, 2022.
The High Outlier badge above means this manufacturer's average price in the Tadalafil market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/5mL
Manufacturer
CMP Pharma, Inc.NDC
46287004515
Classification
Brand
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
10/1/2026
Active Ingredients
TADALAFILApproval Type
New Drug (NDA)
FDA Application
NDA214522FDA Approved
6/17/2022
On Market Since
8/30/2022
Pharmacological Classes
Price Statistics
The NADAC for TADLIQ 20 MG/5 ML SUSPENSION has been published 85 times since Jun 19, 2024, and over the history we have for it it has risen 13.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.5931 per ML |
|---|---|
| All-time high | $13.5931 (Sep 30, 2026) |
| All-time low | $11.9603 (Sep 18, 2024) |
| 52-week high | $13.5931 |
| 52-week low | $12.7665 |
| Median price | $12.2755 |
| Average price | $12.4118 |
| Largest weekly change | +4.0% (Sep 30, 2026) |
| Weeks tracked | 85 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Tadalafil market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Weekly brief
Featured in the latest weekly brief
This NDC appears in the current executive summary of the most important weekly NADAC moves.
Manufacturer
CMP Pharma, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Tadalafil market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphodiesterase 5 Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TADLIQ 20 MG/5 ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for TADLIQ 20 MG/5 ML SUSPENSION, manufactured by CMP Pharma, Inc., is $13.5931 per ML (NDC 46287004515), effective Sep 30, 2026.
How has the price of TADLIQ 20 MG/5 ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for TADLIQ 20 MG/5 ML SUSPENSION has risen 13.6%. It has been tracked across 85 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for TADLIQ 20 MG/5 ML SUSPENSION?
Since Jun 19, 2024, the NADAC for TADLIQ 20 MG/5 ML SUSPENSION has ranged from a low of $11.9603 (Sep 18, 2024) to a high of $13.5931 (Sep 30, 2026), with a median of $12.2755 per ML.
Are there cheaper alternatives to TADLIQ 20 MG/5 ML SUSPENSION?
No other NADAC-published product currently shares the active ingredient and strength of TADLIQ 20 MG/5 ML SUSPENSION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TADLIQ 20 MG/5 ML SUSPENSION?
TADLIQ 20 MG/5 ML SUSPENSION (NDC 46287004515) is labeled by CMP Pharma, Inc., and CMS classifies it as a brand product.